ライフサイエンスコーパス: postoperatively

1 ) had recurrence of macular fluid (14 months postoperatively).

2 point (2.5% deaths and 1% strokes at 30 days postoperatively).

3 s (mean CNFL: 14.67 +/- 7.92 mm/mm(2) 1 year postoperatively).

4 d transfusions from randomisation to 30 days postoperatively.

5 hin 180 days and 13.6% (120/881) at any time postoperatively.

6 ve increase in arm volume arising > 3 months postoperatively.

7 Twelve (26.7%) patients died postoperatively.

8 No IOP-lowering prophylaxis was used postoperatively.

9 tients were exposed to high risk prescribing postoperatively.

10 se as continued opioid fills beyond 3 months postoperatively.

11 and undercorrection rates peaked at 2 years postoperatively.

12 or bleeding was assessed until 10 to 13 days postoperatively.

13 s were conducted preoperatively and 3 months postoperatively.

14 ore of >=3.5 of 5 and required no spectacles postoperatively.

15 ree counterpart, especially within 24 months postoperatively.

16 abetic Retinopathy Study (ETDRS) letter gain postoperatively.

17 tained to study the inner retinal morphology postoperatively.

18 Patients were followed up at least 2 years postoperatively.

19 erimetry were performed at 1, 3 and 6 months postoperatively.

20 3) 24 hours postoperatively, and 4) 72 hours postoperatively.

21 may help face an increased work of breathing postoperatively.

22 king using the Dresden protocol, at 3 months postoperatively.

23 n scores in rest and when moving at 24 hours postoperatively.

24 ropriate interventions that support patients postoperatively.

25 This was also true at 12 months postoperatively.

26 ed via intraperitoneal injection for 2 weeks postoperatively.

27 on the shrinkage ratio of graft at 6 months postoperatively.

28 ted to LRYGB versus LSG in the first 30 days postoperatively.

29 ipants underwent screening duplex ultrasound postoperatively.

30 P < 0.05) better in the LL group at 9 months postoperatively.

31 n = 67) were evaluated 36, 48, and 60 months postoperatively.

32 en given high-dose immunosuppressive therapy postoperatively.

33 revascularization, or stroke within 90 days postoperatively.

34 Subjects were followed through 2 years postoperatively.

35 significant improvement was found six months postoperatively.

36 vasopressor requirement than EP up to 2 days postoperatively.

37 arkable and each patient's symptoms resolved postoperatively.

38 ts had stable long-term satisfaction and QOL postoperatively.

39 sRNFL resolved in all cases postoperatively.

40 preoperatively as well as at 3 and 12 months postoperatively.

41 ed 1 day, 1 week, and 1, 3, 6, and 12 months postoperatively.

42 89% cumulative graft success rate at 1 year postoperatively.

43 , 1 week, and 1, 3, 6, 12, 18, and 24 months postoperatively.

44 d a corneal hydrops, evident both intra- and postoperatively.

45 ted distance visual acuity and OCT thickness postoperatively.

46 ere evaluated at baseline and 3 and 6 months postoperatively.

47 .94; 95% CI, -7.01 to 1.12; P = .15) 2 years postoperatively.

48 d 1 patient with an IOL exchange at 8 months postoperatively.

49 e (NEI-VFQ) 30 to 90 days preoperatively and postoperatively.

50 ampton wound score of less than 2 at 30 days postoperatively.

51 summary scores pre-implantation and 3 months postoperatively.

52 - 10.3) to 24.9 (+/- 10.6) mm Hg at 6 months postoperatively.

53 nd at 6 months, 1 year, 2 years, and 4 years postoperatively.

54 e 30.4 months preoperatively and 40.6 months postoperatively.

55 of the ulnar artery was required a few hours postoperatively.

56 s pretreatment and at 3, 6, 9, and 12 months postoperatively.

57 rhea (P= 0.038) scores increased at 3 months postoperatively.

58 sed preoperatively and at 1, 3, and 6 months postoperatively.

59 tively and at 10 days, 6 weeks, and 3 months postoperatively.

60 eoperatively and at 2 to 5 days and 3 months postoperatively.

61 difference in anxiety levels between groups postoperatively.

62 rded at follow-up visits every 3 to 6 months postoperatively.

63 ed for renal replacement therapy at any time postoperatively.

64 fill were recorded at baseline and 9 months postoperatively.

65 orting interventions that might be necessary postoperatively.

66 ed single-layered flaps intraoperatively and postoperatively.

67 depth were recorded at baseline and 9 months postoperatively.

68 recurrence and risk-stratification pre- and postoperatively.

69 an average follow-up of 49.1 +/- 26.8 months postoperatively.

70 nd 90 days (31.8[95%CI 5.44,58.1],p = 0.018) postoperatively.

71 culated to Area Under Curve (AUC) for 1 year postoperatively.

72 days after extubation, and 1, 3, and 5 years postoperatively.

73 gery are at increased risk of adverse events postoperatively.

74 as measured 30 to 90 days preoperatively and postoperatively.

75 or to DMEK and at 1, 3, 6, 12, and 24 months postoperatively.

76 and Tm were diminished due to the diet used postoperatively.

77 ficant difference was maintained at 3 months postoperatively.

78 RHAL gain when compared with groups 1 and 2 postoperatively.

79 ale) were assessed preoperatively and 1 year postoperatively.

80 d as moderate pain lasting at least 3 months postoperatively.

81 cted preoperatively and at regular intervals postoperatively.

82 ed pre-treatment, preoperatively, and 1 year postoperatively.

83 tively, pre- and postadjustment, and 6 weeks postoperatively.

84 essed preoperatively, 1, 3, 6, and 12 months postoperatively.

85 sfaction and spectacle independence 3 months postoperatively.

86 al equivalent was -0.04 +/- 0.321 D 3 months postoperatively.

87 ts were compared preoperatively and 3 months postoperatively.

88 can also be applied both preoperatively and postoperatively.

89 ween treatments were found in the first week postoperatively.

90 visit or inpatient admission within 30 days postoperatively.

91 ive refraction was performed at 4 to 6 weeks postoperatively.

92 proved from 5.5 mm preoperatively to 31.5 mm postoperatively.

93 ntly reduces the incidence of SSI at 30 days postoperatively.

94 rimary endpoint was SSI incidence at 30 days postoperatively.

95 hange were recorded at baseline and 9 months postoperatively.

96 ful medication reduction for up to 12 months postoperatively.

97 Eleven infants died postoperatively.

98 Animals were euthanized 30 days postoperatively.

99 filled an opioid prescription within 30 days postoperatively.

100 e of venous thromboembolism at 10 to 13 days postoperatively.

101 ear and followed them until death or 4 years postoperatively.

102 were assessed prior to STN-DBS and 3 months postoperatively.

103 patients continue to have disabling seizures postoperatively.

104 17)%, and 52 (+/-18)% at 1, 6, and 48 months postoperatively.

105 aseline, 76.3% of eyes had fewer medications postoperatively.

106 CD may show the lowest endothelial cell loss postoperatively.

107 functionality and pain 6, 12, and 60 months postoperatively.

108 erse events were assessed at least 12 months postoperatively.

109 ollected at baseline and at 1-, 3-, and 6 mo postoperatively.

110 duces excellent outcomes throughout 10 years postoperatively.

111 1264 (1.4%) required ICU admission >24 hours postoperatively.

112 tral gradients at peak exercise at 12 months postoperatively.

113 reased by 59% at 5 years and 68% at 10 years postoperatively.

114 y second-eye cataract surgery within 90 days postoperatively.

115 ) for pain management (control) over 30-days postoperatively.

116 day, 1 week, 6 weeks, 3 months, and 6 months postoperatively.

117 performed at baseline, 6, 12, and 24 months postoperatively.

118 ne but may increase the risk of constipation postoperatively.

119 hirmer's test; BST), both preoperatively and postoperatively.

120 ontinuously from enrollment through 6 months postoperatively.

121 matory markers were evaluated, up to 90 days postoperatively.

122 multiple gingival recessions after 6 months postoperatively.

123 patients had reduction in excess limb volume postoperatively.

124 strabismus, and were evaluated several times postoperatively.

125 duced 2 factors preoperatively and 3 factors postoperatively.

126 nal status and reduced affected limb volumes postoperatively.

127 ively, and at 6 weeks, 6 months, and 2 years postoperatively.

128 n score were higher for PCA at rest 24 hours postoperatively (0.59 [0.30, 0.88]), and with movement a

129 [0.30, 0.88]), and with movement at 48 hours postoperatively (0.95 [0.31, 1.60].

130 Three years postoperatively, 11.4% of patients had an Nd:YAG capsulo

131 P-1 was significantly increased from 10 days postoperatively (2.4 +/- 0.2-fold increase, P < 0.01), a

132 d 14 (17.9%) receiving 1.8 mg/kg of osocimab postoperatively; 23 (29.9%) receiving 0.3 mg/kg and 9 (1

133 ital stay was 1 to 9 days across specialties.Postoperatively, 26 patients were tested for COVID 19 an

134 Postoperatively, 3 of 5 patients had near complete (0-5

135 Postoperatively, 38 (14.67%) cases of anastomotic leakag

136 Postoperatively, 38/64 (59%) were diagnosed with jejunal

137 There was no difference in SSIs at 4 days postoperatively [4.1% vs 8.0%, P = 0.516 (1-sided), P =

138 preoperatively to 61.1 +/- 12.5 mm(2) 1 year postoperatively (66.9% increase).

139 eoperative QoV scores improved significantly postoperatively (7.5 +/- 0.8 vs. 9.1 +/- 0.7; P < 0.001)

140 Ninety-three eyes had improved vision postoperatively (91.18%).

141 y risk when chemotherapy was started 50 days postoperatively (95% CI, 39-56 days).

142 Postoperatively a combination of H-FABP, midkine and sTN

143 The recipient developed postoperatively a slight small for size syndrome which s

144 endpoint was the rate of SSI within 30 days postoperatively according to Centers for Disease Control

145 Postoperatively, AKI was associated with atrial fibrilla

146 - 0.5-fold at 10 days, 6 weeks, and 3 months postoperatively (all P < 0.0001).

147 At 6 months postoperatively, all FTMHs closed and BCVA were signific

148 Body weight loss at 6 weeks and 3 months postoperatively among 13 patients undergoing esophagecto

149 One of those had no vertical deviation postoperatively and 1 patient resulted in 2Delta hypotro

150 n rates (to minimal) were 100% at 2-5 months postoperatively and 86% at last follow-up (P < .0001 at

151 al edges demonstrated a 2-fold increase 1 mo postoperatively and a 10-fold increase at 6 mo in normog

152 by specular microscopy at least three months postoperatively and analyzed.

153 were followed-up every 6 months for 3 years postoperatively and global health assessed with EORTC-QL

154 ignificantly correlated with CDVA six months postoperatively and NCVA, while the trefoil, internal hi

155 ngle alpha could predict the CDVA six months postoperatively and NCVA.

156 ollow-up was performed approximately 4 weeks postoperatively and then after 4, 8, 12, 18, and 24 mont

157 first dose of analgesic at home, 3) 24 hours postoperatively, and 4) 72 hours postoperatively.

158 +/-8)% at, respectively, 1, 6, and 48 months postoperatively, and 59 (+/-10)%, 64 (+/-9)%, and 75 (+/

159 e measured preoperatively and up to 48 hours postoperatively, and cognitive function was assessed pre

160 y, weights stabilize at about 6 to 12 months postoperatively, and patients report outcomes as being g

161 ickness [CCT]) were evaluated up to 10 years postoperatively, and postoperative complications were do

162 the probability of glaucoma control vs time postoperatively, and values were compared between angle

163 (CCT) and endothelial cell density 12 months postoperatively; and intraoperative and postoperative co

164 Postoperatively, anterior segment optical coherence tomo

165 Control Test (ACT) at baseline and 6 months postoperatively as part of a multi-institutional, prospe

166 Plasma was collected pre- and postoperatively as well as at d1, d3, d5 and d8 after su

167 nctival 5-fluorouracil injections were given postoperatively, as needed.

168 stically significant decrease in impulsivity postoperatively, as quantified by the Barratt Impulsiven

169 ective primary hip or knee arthroplasty were postoperatively assessed for delirium once-daily for thr

170 mboembolism incidence between 10 and 13 days postoperatively (assessed by mandatory bilateral venogra

171 web-based questionnaire, preoperatively and postoperatively at 1 and 3 months (the PROWL-1 and -2 st

172 serial serum sampling (preoperatively day 0; postoperatively at 1 week, 1 month, and 12 months).

173 OCTA was performed at 1 week, 1 and 3 months postoperatively at the CAG transplantation site and harv

174 he amount of root coverage achieved 3 months postoperatively at the recipient site.

175 proved to 1.5+/- 0.7 logMAR and 1.49+/- 0.98 postoperatively, at 1- and 2-year follow-up visit.

176 perative value of 29.1+/- 9.7 to 18.7+/- 7.2 postoperatively, at 2-year follow-up.

177 admission triage, developed COVID-pneumonia postoperatively, at a median of 7 days after CS.

178 e ability to identify risk of developing AKI postoperatively (AUROC 0.748).

179 -MORAL was constructed similarly using the 4 postoperatively available independent predictors of wors

180 als, postoperative healing, medications used postoperatively, bone growth, and density changes as qua

181 leads to more reinterventions within 30 days postoperatively, but does not increase the 30 or 90-day

182 ts, protective ILC3s repopulate by 2-4 weeks postoperatively, but in rejecting allografts they remain

183 sity focused ultrasound reduced IOP 3 months postoperatively by 16% and aqueous flow decreased by 15%

184 ges from incised BCS specimens were analyzed postoperatively by 2 surgeons blinded to the histopathol

185 , whereas PF and FA remained impaired 1 year postoperatively (Cohen's d: 0.52 and -0.53, respectively

186 (mean +/- standard deviation) at 3 to 4 days postoperatively compared to baseline (p = 0.023), recove

187 ent groups, all end points declined 3 months postoperatively compared with baseline (Cohen's d: -1.00

188 Postoperative complications up to 2 years postoperatively comprised pupillary block in 1 eye (succ

189 ent cancer surgery and associated with lower postoperatively daily physical activity.

190 Postoperatively, data were reviewed for complications an

191 One year postoperatively, DCN and ICN showed comparable outcomes.

192 ltaBCVA from baseline at 3, 6, and 12 months postoperatively, endothelial cell loss (%ECL), rebubblin

193 Postoperatively, esotropia and head turn were corrected

194 Steroids were used postoperatively following various horizontal ridge augme

195 thesia, and participants were assessed daily postoperatively for delirium.

196 s were performed preoperatively and CT scans postoperatively for localisation of electrodes.

197 vodopa-induced dyskinesias could be elicited postoperatively, GIDs were never observed in any animal

198 Three months postoperatively, GLP-1 area under the curve was associat

199 , Shoulder, and Hand score was 50 versus 18, postoperatively; his Short Form-36 score was 90.

200 Results of the Amsler test were abnormal postoperatively in 54% of the patients in the group with

201 d the clinical progress and function 7 years postoperatively in a patient who underwent bilateral PFT

202 dehisced ILM intraoperatively, and resolved postoperatively in all cases.

203 nternet preoperatively and at 1 and 3 months postoperatively in both studies and at 6 months postoper

204 25b-5p returned towards HC levels at 1 month postoperatively in patients without disease, whereas rem

205 toperatively in both studies and at 6 months postoperatively in PROWL-1.

206 Five patients died postoperatively in-hospital due to complications (6%).

207 pioid filled per prescription within 30 days postoperatively [in oral morphine equivalents (OME)].

208 participants received all 3 mHELP protocols postoperatively, in addition to usual care, as soon as t

209 o 0.2 mug/kg per h at the end of bypass, and postoperatively increased to 0.4 mug/kg per h, which was

210 At 3 months postoperatively, mean UDVA difference between treatment

211 Postoperatively, mean unaided visual acuity was 6/12 (20

212 Osocimab given postoperatively met criteria for noninferiority compared

213 At 1 year postoperatively (n = 15 eyes), BCVA improved by >=2 Snel

214 Postoperatively, neither complications nor changes in PD

215 At 12 weeks postoperatively, none of SEAP group showed any signs of

216 on of 2-hydroxyglutarate, currently assessed postoperatively on biopsied tissue using immunohistochem

217 equired more vasopressor support immediately postoperatively on day 0 (14% vs 54%, P = <0.001) and da

218 an esophagectomy are often kept nil-by-mouth postoperatively out of fear for increasing anastomotic l

219 6/20 (20/63) preoperatively to 6/10 (20/32) postoperatively (P < .05).

220 Mean BCVA improved 13.5% postoperatively (P < 0.00001) and CSF improved 53% (P <

221 ly to 0.40+/-0.55 (20/50 Snellen equivalent) postoperatively (P < 0.001).

222 8 mmHg preoperatively to 20.18 +/- 0.83 mmHg postoperatively (p < 0.001).

223 Blood perfusion rate decreased immediately postoperatively (P < 0.01, GG) followed by 3-day hyperem

224 (14-55Delta) to 12 +/- 9.8Delta (0-22Delta) postoperatively (P = .02).

225 -4.4 +/- 0.5 preoperatively to -3.4 +/- 0.9 postoperatively (P = .07).

226 operative 0.26 +/- 0.12 D to 0.26 +/- 0.10 D postoperatively (P = .625).

227 quivalent values also improved significantly postoperatively (p = 0.003).

228 eline narcotic use (P = 0.004), highest pain postoperatively (P = 0.004), and incision length (P = 0.

229 r in the TTIL group than in TAMK for 2 years postoperatively (P = 0.036).

230 5-point difference in mean score at 3 months postoperatively (P = 0.037).

231 Postoperatively, patients could experience spectacle dep

232 At 3 months postoperatively, patients with UEL had a 31.1% reduction

233 ively (PREOP), and 2 days (POD2) and 30 days postoperatively (PO1MO) using Simoa technology (Quanteri

234 ratively (Pre), 1 month (Pos1M) and 3 months postoperatively (Pos3M).

235 myelinated afferents, nodal length increased postoperatively [pre: 2.03 (0.82), post: 3.03 (1.23), P

236 nse: PSA levels < 0.2 ng/mL at 6 wk and 6 mo postoperatively, PSA level >= 0.2 ng/mL was biochemical

237 early feeding as feeds commenced <=24 hours postoperatively (range 2-72 hours).

238 nd radiological and endoscopic data were pre/postoperatively recorded.

239 groups on vertex-wise analysis, the areas of postoperatively reduced thinning were in both hemisphere

240 hacoemulsification and 38.1% (OS) six months postoperatively respectively.

241 11), and 71% (n = 11) at 1, 6, and 12 months postoperatively, respectively.

242 ers and were more likely to gain >=5 letters postoperatively, respectively.

243 =20/25 (decimal VA >=0.8) at 5- and 10 years postoperatively, respectively.

244 of 16.6% and 21.5% from 6 months to 10 years postoperatively, respectively.

245 d 0.79 (95% CI, 0.70-0.88) at 5 and 10 years postoperatively, respectively.

246 , 50% vs. 20%, preoperatively vs. >24 months postoperatively, respectively; P < 0.001).

247 - 319 mg/dL, preoperatively vs. 12-24 months postoperatively, respectively; P = 0.0001).

248 - 4.1 mg/dL, preoperatively vs. 12-24 months postoperatively, respectively; P = 0.02), but not in ALG

249 AKI occurred if, within 48 hours postoperatively, serum creatinine rose by 50% or by 0.3

250 ear, as the majority of evidence is based on postoperatively stable patients.

251 PCM + IBU) orally every 6 hours for 24 hours postoperatively, starting 1 hour before surgery.

252 % can proceed to LT, with half being able to postoperatively stop medication.

253 I], 61.1-139; P < 0.05) gained fewer letters postoperatively than the overall average, whereas those

254 From 3 to 12 months postoperatively, the asymmetrical group presented a mean

255 Postoperatively, the patient developed hypertriglyceride

256 Postoperatively, the patient experienced an improvement

257 One year postoperatively, the UCDVA and CDVA were 20/25 and 20/20

258 At 6 weeks postoperatively there was expected excyclodrift (to mean

259 atients no longer required insulin at 1-year postoperatively: these rates persisted for 4 years.

260 The alveolar ridge was measured pre- and postoperatively to evaluate change in ridge height and w

261 ies are increasingly used preoperatively and postoperatively to improve postoperative outcomes.

262 UROCs) were generated for biomarkers pre and postoperatively to stratify patients at risk of AKI.

263 Chronic EC loss was calculated from 6 months postoperatively to the end of follow-up and showed an an

264 MAIN OUTCOME MEASURE(S): At 3 months postoperatively, UCVA and DCVA in 4 m, 80 cm, 60 cm, and

265 ergoing surgical repair were imaged pre- and postoperatively using magnetic resonance imaging.

266 video and snapshots were analysed intra- and postoperatively using post-processing approach using gra

267 Three months postoperatively, valve-specific quality of life and regr

268 n = 94), preoperatively (5 days orally), and postoperatively via a jejunostomy until 1 month postdisc

269 as marked variation in how and at what point postoperatively visual outcomes following cataract, corn

270 was 2.5 (range 0-5, mean 2.6); median number postoperatively was 1 (range 0-4, mean 1.6).

271 The mean basal IOP was 17.0 +/- 3.7 mmHg and postoperatively was 11.6 +/- 1.9 mmHg and 11.4 +/- 1.8 m

272 n 180 days was 9.5% (84/881) and at any time postoperatively was 23.3% (205/881).

273 Maximum mean IOP postoperatively was 25.2 +/- 7.4 for control eyes and 16

274 l, the rate of reintervention within 30 days postoperatively was 45/159 (28.3%) in the lavage group a

275 The angle alpha preoperatively and postoperatively was correlated with the postoperative vi

276 The number of adjunct analgesics used postoperatively was greater in the ERAS group (median 3

277 The incidence of SSI at 30-days postoperatively was no different between experimental an

278 cted distance visual acuity (CDVA) one month postoperatively was significantly better than the preope

279 The incidence of SSI at 30 days postoperatively was significantly reduced in the treatme

280 Endothelial cell density at 1 month postoperatively was similar between groups in diabetics

281 Endothelial cell loss at 6 months postoperatively was similar for phakic and pseudophakic

282 f the external limiting membrane at 3 months postoperatively was the only significant feature correla

283 hmark values for both RYGB and SG at 90-days postoperatively were 5.5% Clavien-Dindo grade >=IIIa com

284 rgery, and were disease-free at least 1 year postoperatively were asked to complete LASER, EORTC-QLQ-

285 Larger bet sizes in the virtual casino postoperatively were associated with greater connectivit

286 rative bleb needling (28.6%) and at any time postoperatively were bleb needling (36.1%), bleb revisio

287 lar alignment, and torsion preoperatively to postoperatively were compared.

288 in of moderate to severe intensity at 1 year postoperatively were developed by logistic regression an

289 tenance medications during the first 3 years postoperatively were tacrolimus, mycophenolate, and ster

290 5 patients, 3 died from persistent infection postoperatively, whereas 8 underwent retransplantation w

291 drainage (Tbili <=1.5 mg/dL within 3 months postoperatively), which is highly predictive of increase

292 y and 69.6% ECD remained at the 15(th) month postoperatively while similar ECD of right eye before an

293 (whilst 'on' medication) and again, 3-months postoperatively (whilst 'on' stimulation).

294 20% of eyes required reoperation at any time postoperatively with a mean follow-up of nearly 3 years.

295 d significantly better survival up to 1 year postoperatively with a risk reduction of 57% (hazard rat

296 rates were compared between patients treated postoperatively with topical steroids, nonsteroidal anti

297 if hemoglobin<7.5 g/dl, intraoperatively and postoperatively) with a liberal threshold (transfuse if

298 inal reattachment was maintained at 6 months postoperatively, with a corresponding improvement in vis

299 Postoperatively, women who chose CPM with implant recons

300 tant aspirin and therapeutic anticoagulation postoperatively, yet the safety of this practice remains